Mipomersen - Kastle Therapeutics
At a glance
- Drug Originator Isis Pharmaceuticals
- Drug Licenced by TRPHARM
- Drug Class Antihyperlipidaemics; Antisense oligonucleotides; Oligodeoxyribonucleotides
- Mechanism of Action Apolipoprotein B-100 expression inhibitors; RNA interference
- USA Patent Applicants KASTLE THERAPS LLC
- USA Patents 13
- NDAs 1
- International Patents 45
Disclaimer